119-hr742

HR
✓ Complete Data

PROTECTS Act of 2025

Login to track bills
Introduced:
Jan 28, 2025
Policy Area:
Health

Bill Statistics

3
Actions
38
Cosponsors
1
Summaries
4
Subjects
1
Text Versions
Yes
Full Text

AI Summary

No AI Summary Available

Click the button above to generate an AI-powered summary of this bill using Claude.

The summary will analyze the bill's key provisions, impact, and implementation details.

Latest Action

Jan 28, 2025
Referred to the House Committee on Energy and Commerce.

Summaries (1)

Introduced in House - Jan 28, 2025 00
<p><strong>Protecting Resources Of Taxpayers to Eliminate Childhood Transgender Surgeries Act of 2025 or the PROTECTS Act of 2025</strong></p><p>This bill prohibits providing or using federal funds to perform, refer for, or reimburse any entity for certain&nbsp;gender transition procedures for an individual under the age of 18.&nbsp;</p><p>The bill’s prohibition applies to certain gender transition procedures that are&nbsp;performed to intentionally change an individual’s body to no longer correspond to the individual's&nbsp;biological&nbsp;sex, including surgeries, medications, and implants specified in the bill. The bill provides exceptions for specified procedures, such as treating certain genetic abnormalities or preventing imminent death or impairment of a major bodily function, when performed by a health care provider with the consent of the individual’s parent or legal guardian.&nbsp;</p>

Actions (3)

Referred to the House Committee on Energy and Commerce.
Type: IntroReferral | Source: House floor actions | Code: H11100
Jan 28, 2025
Introduced in House
Type: IntroReferral | Source: Library of Congress | Code: Intro-H
Jan 28, 2025
Introduced in House
Type: IntroReferral | Source: Library of Congress | Code: 1000
Jan 28, 2025

Subjects (4)

Child health Health (Policy Area) Sex, gender, sexual orientation discrimination Surgery and anesthesia

Cosponsors (20 of 38)

Showing latest 20 cosponsors

Text Versions (1)

Introduced in House

Jan 28, 2025

Full Bill Text

Length: 5,947 characters Version: Introduced in House Version Date: Jan 28, 2025 Last Updated: Nov 13, 2025 6:28 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 742 Introduced in House

(IH) ]

<DOC>

119th CONGRESS
1st Session
H. R. 742

To prohibit Federal funds from being used to provide certain gender
transition procedures to minors.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

January 28, 2025

Mr. McCormick (for himself, Mr. Clyde, Mrs. Luna, Mr. Scott Franklin of
Florida, Ms. Van Duyne, Mr. Fallon, Mr. Collins, Mr. Weber of Texas,
Mr. Harris of Maryland, Mr. Grothman, Mr. Guest, Mr. Zinke, Mr. Babin,
Mr. Moore of West Virginia, Mr. Ellzey, Mr. Norman, Mr. Webster of
Florida, Mr. Arrington, Mr. Wied, Mr. Rose, Mr. Austin Scott of
Georgia, Mr. Hamadeh of Arizona, Mr. Baird, Mr. Owens, Mr. Gooden, Mr.
Jackson of Texas, Mr. Finstad, Mr. McGuire, Mr. Johnson of South
Dakota, Mr. Ogles, and Mr. Gosar) introduced the following bill; which
was referred to the Committee on Energy and Commerce

_______________________________________________________________________

A BILL

To prohibit Federal funds from being used to provide certain gender
transition procedures to minors.

Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1.

This Act may be cited as the ``Protecting Resources Of Taxpayers to
Eliminate Childhood Transgender Surgeries Act of 2025'' or the
``PROTECTS Act of 2025''.
SEC. 2.
GENDER TRANSITION PROCEDURES TO MINORS.

(a) In General.--Notwithstanding any other provision of law, no
Federal funds may be used or otherwise made available to provide or
refer for a specified gender transition procedure to an individual
under the age of 18 or to reimburse any entity for providing such a
procedure to such an individual.

(b) Specified Gender Transition Procedure Defined.--

(1) In general.--For purposes of this paragraph, except as
provided in paragraph

(2) , the term ``specified gender
transition procedure'' means, with respect to an individual,
any of the following when performed for the purpose of
intentionally changing the body of such individual to no longer
correspond to their sex:
(A) Performing any surgery, including--
(i) castration;
(ii) orchiectomy;
(iii) scrotoplasty;
(iv) vasectomy;
(v) hysterectomy;
(vi) oophorectomy;
(vii) ovariectomy;
(viii) metoidioplasty;
(ix) penectomy;
(x) phalloplasty;
(xi) vaginoplasty;
(xii) vaginectomy;
(xiii) vulvoplasty;
(xiv) reduction thyrochondroplasty;
(xv) chondrolaryngoplasty;
(xvi) mastectomy; and
(xvii) any plastic, cosmetic, or aesthetic
surgery that feminizes or masculinizes the
facial or other body features of an individual.
(B) Any placement of chest implants to create
feminine breasts.
(C) Any placement of fat or artificial implants in
the gluteal region.
(D) Administering, supplying, prescribing,
dispensing, distributing, or otherwise conveying to an
individual medications, including--
(i) gonadotropin-releasing hormone

(GnRH) analogues or other puberty-blocking drugs to
stop or delay normal puberty; and
(ii) testosterone, estrogen, or other
androgens to an individual at doses that are
supraphysiologic than would normally be
produced endogenously in a healthy individual
of the same age and sex.

(2) Exception.--Paragraph

(1) shall not apply to the
following when furnished to an individual by a health care
provider with the consent of such individual's parent or legal
guardian:
(A) Puberty suppression or blocking prescription
drugs for the purpose of normalizing puberty for an
individual experiencing precocious puberty.
(B) Appropriate and medically necessary procedures
or treatments to correct for--
(i) a medically verifiable genetic disorder
of sex development, including--
(I) 46,XX chromosomes with
virilization;
(II) 46,XY chromosomes with
undervirilization; and
(III) both ovarian and testicular
tissue;
(ii) sex chromosome structure, sex steroid
hormone production, or sex hormone action, if
determined to be abnormal by a physician
through genetic or biochemical testing; or
(iii) infection, disease, injury, or
disorder caused or exacerbated by a previous
procedure described in paragraph

(1) , or a
physical disorder, physical injury, or physical
illness that would, as certified by a
physician, place the individual in imminent
danger of death or impairment of a major bodily
function unless the procedure is performed, not
including procedures performed for the
alleviation of mental distress.

(3) Certain terms.--For purposes of this section:
(A) Sex.--The term ``sex'', when referring to
individual's sex, shall be understood to refer to
either male or female, as biologically determined.
(B) Female.--The term ``female'', when referring to
a natural person, means an individual who naturally
has, had, will have, or would have, but for a
developmental or genetic anomaly or historical
accident, the reproductive system that at some point
produces, transports, and utilizes eggs for
fertilization.
(C) Male.--The term ``male'', when referring to a
natural person, means an individual who naturally has,
had, will have, or would have, but for a developmental
or genetic anomaly or historical accident, the
reproductive system that at some point produces,
transports, and utilizes sperm for fertilization.
<all>